Multiple Sclerosis Resource Centre
  • Home
  • World MS Day (Green Day)
  • About MS
  • MSRC Services
  • Get Involved
  • MS Research News
  • MSRC Groups
  • Useful Resources
  • Advertising
  • MSRC Guest Book
  • Best Bet Diet Group
  • E-Newsletter
  • Contact Us
  • Investor in People
    You are here : Home » The Best Bet Diet Group » Online Newsletter » Past Newsletter Articles » BBD Science and Research Articles » Article 28: Skin Cancer in PwMS

    Article 28: Skin Cancer in PwMS

    A A A
    [Print this page]

    Share |


    RESEARCH REPORT Skin cancer in people with multiple sclerosis: a record linkage study M J Goldacre, V Seagroatt, D Yeates, E D Acheson

    J Epidemiol Community Health 2004;58:142?144

    Objective: The prevalence of multiple sclerosis (MS) varies with latitude: it increases with distance from the equator in both hemispheres. To seek evidence on whether solar radiation is a protective factor for MS, this study investigated whether skin cancer, as an indicator of solar radiation, is less common in people with MS than in others.

    Design: Analysis of a database of linked hospital records and death certificates.

    Setting: The Oxford Region of the National Health Service, England.

    Subjects: A cohort comprising all people in the database with MS, and comparison cohorts of people with other diseases.

    Results: Skin cancer was significantly less common in people with MS than in the main comparison cohort (rate ratio 0.49; 95% confidence interval 0.24 to 0.91). There was no general deficit of cancer in the MS cohort, and no deficit of skin cancer in cohorts of people with other autoimmune or neurological diseases.

    Conclusion: The findings support the hypothesis that solar radiation may have a protective influence on the development of MS.

    The aetiology of multiple sclerosis (MS) remains obscure, but its remarkable global distribution may provide a clue to part of its causation. Among Europeans who have settled in North America, South Africa, Australia, and New Zealand there is a close relation between the prevalence of the disease and distance from the equator.

    In North America MS is more common in Canada and the northern states of the USA than in the southern states, while in the southern hemisphere there is a regular gradation in the prevalence of MS in the opposite direction? from south to north.

    These findings led to the suggestion that ??the more sunshine there is in a climate the less MS there appears to be?? and the hypothesis that ??such an influence could conceivably act directly, a certain skin dose of sunshine per unit time protecting the individual in some way??.2 One of the sun associated factors that showed a strong inverse correlation with MS in North American studies was lack of winter sunshine. This suggests that a minimum exposure throughout the year may be necessary to confer protection. Recent work has suggested that, as a mechanism, solar radiation might be one of the factors that influence the development of MS through an effect on the immune system.

    It is generally accepted that the direct effect of solar radiation on skin is an important cause of skin cancer in fair skinned people. Most squamous and basal cell carcinomas in fair skinned people occur on sun exposed skin and are related to affected individuals? cumulative dose of solar radiation. Solar keratoses commonly precede the development of squamous cell carcinoma. There is also strong evidence that solar radiation contributes to the aetiology of melanoma of the skin in some way, but the association with duration of exposure to sunlight is less linear than that for the epithelial skin cancers. The association with melanoma may be related, in part, to intermittent, recreational sun exposure.

    If solar radiation protects against MS, people with MS might have a lower than average risk of skin cancer. We tested this hypothesis using data from the Oxford record linkage study (ORLS).

    METHOD The ORLS includes brief statistical abstracts of records of all hospital admissions (including day cases) in National Health Service (NHS) hospitals, and all deaths regardless of where they occurred, in defined populations within the former Oxford NHS region, from 1 January 1963 to 31 March 1999.

    The hospital data were collected routinely in the NHS as hospital discharge statistics. They exclude patients treated in the private sector. The data about deaths were obtained by the ORLS from death certificates. Data collection covered two health districts from 1963 (population 850 000), six districts from 1975 (population 1.9 million) and all the eight districts of the region from 1987 (population 2.5 million). The data for each person were linked together routinely as part of the Oxford region's health information systems.

    The MS cohort was obtained by selecting records of people aged 15 years and over with an admission for MS. The admission date was that of the first recorded admission for MS. It is not necessarily the first ever admission, which could have occurred outside the area covered by the database or before the start of the database. A reference cohort was constructed by similarly selecting records of people aged 15 years and over who had been admitted for various medical and surgical conditions. This was drawn from a standard ??reference?? group of patients that has been used in other studies of inter-relations between diseases. We identified any subsequent inpatient or day case care for skin cancers, and for all cancers, in these cohorts. We considered that the cancer rates in the reference cohort would approximate to those in the general population of the region while permitting for migration from it (data on migration of people were not available).

    Related Items
    Article 01: Theory Attacks MS Diagnosis
    Article 02: Ponsenby et al UVB Review
    Article 03: Celtic Gene - Link to MS
    Article 04: MS in the Canaries
    Article 05 Two Phases of MS
    Article 06: Infants Should Be Supplemented with Vitamin D says EU Committee
    Article 07: Cytokine Profile in Patients with Multiple Sclerosis Following Vitamin D Supplementation
    Article 08: Starvation May Help MS
    Article 09: Ginko Biloba
    Article 10: CLA Reduces Leptin Levels
    Article 11: Doctors Seek Better Treatments for MS
    Article 12: RA and Mediteranian Diet
    Article 13: Mediteranian Diet and RA (Paper 2)
    Article 14: Vit D in Preventative Medicine - Are we Ignoring the Evidence?
    Article 15: Interferon Treatment of MS Questioned
    Article 16: MS in African/American Women
    Article 17: Mercury in Fish
    Article 18: Can Vitamin D impact MS?
    Article 19: Tip the Scales in Favor of Fish
    Article 20: Does Mercury Matter?
    Article 21: Skin Exposure in Childhood and risk of MS
    Article 22: Iron Deficient Mice Resistant to E.A.E.
    Article 23: High dose antioxidant supplementation to MS patients. Effects on glutathione peroxidase, clinical safety, and absorption of selenium
    Article 24: Vitamin D Supplementation in the Fight Against MS
    Article 25: 40% Reduction in MS Incidence with Vit D Supplementation
    Article 26: Long latency Vit D Deficiency - Robert P.Heaney
    Article 27: Antibody Cross-Reactivity between Myelin Oligodendrocyte Glycoprotein and the Milk Protein Butyrophilin in Multiple Sclerosis
    Article 29: Vitamin D Supplementation During Lactation and Pregnancy
    Article 30: Gluten Antibodies and MS
    Article 31:Glycemic index in chronic disease: a review
    Article 32: Timing of birth and risk of multiple sclerosis: population based study
    Article 33:Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients.
    Article 34: Multiple sclerosis and vitamin D: an update
    Article 35: Discovery Could Lead to Prevention/Treatment of Autoimmune Diseases
    Article 36: Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density.
    Article 37: Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function
    Article 38:Sunlight Prevents Cancer
    Article 39: Assay Variation Confounds the Diagnosis of
    Article 40: Coconut Oil by James South
    Article 41: Scientists say Sunshine May Prevent Cancer
    Article 42: A Vegan Diet changes Intestinal Flora
    Article 43: Ready-to-eat spinach bears tough microbes
    Article 44:UVR, Vitamin D and Three Autoimmune Diseases
    Article 45: Vitamin D Deficiency and Bone Mineral Density
    Article 46: Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients
    Article 47: Omega-3 Fatty Impacts Health and Disease
    Article 48: The Multiple Factors of Multiple Sclerosis: A Darwinian Perspective.
    Article 49: Vitamin D - A Rat Poison Safer than Water
    Article 50: Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients.
    Article 51: A phase I dose escalation study of vitamin D3 with calcium supplementation in patients with multiple sclerosis
    Article 52: First Course; Vitamin D, As in Our Daily Deficiency
    Article 53: Sunlight, Vitamin D and Health - Ian Gibson, MP - Invitation
    Article 54: The truth about soya
    Article 55: Glucosamine and Autoimmunity
    Article 57: Diets with a high glycemic load increase the risk of a myocardial infarction


    Did you find this information useful? Would you like to comment on this page? Let us know what you think! We welcome all comments and feedback on any aspect of our website - please click here to contact us.